Information Provided By:
Fly News Breaks for August 15, 2019
TAK
Aug 15, 2019 | 05:49 EDT
Daiwa analyst Kazuaki Hashiguchi downgraded Takeda Pharmaceutical to Neutral from Outperform with a price target of 3,700 yen, down from 4,500 yen.